RARA CRAFT DATABASE for FDA Medical Devices
510(k)K200445

FDA DEVICE FACTS

The C100 Contactless Breathing Monitor

Circadia Technologies, Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 24, 2020PRODUCT CODEBZQ

Indications for use

Environment Hospital post-acute care settings such as General Care Floors (GCF), Inpatient Rehabilitation Facilities (IRF), and Skilled Nursing Facilities (SNF). Hospital and clinical setting. The general intended environments are hospitals, institutions, sleep centers, the home and sleep clinics or the patient's home. Duration of Monitoring Spot Check and Continuous Measurement Spot Check Sleep Patient Interface Non patient contacting, Non patient contacting, Respiratory effort works from distance through clothing and duvet. works from distance through clothing. bands (chest and abdomen) in direct contact with the subject. Nasal cannula, measures nasal pressure. Measurement positions Subject can be Seated or Lying down Seated Lying down Parameters displayed Respiratory Rate Respiratory Rate Respiratory rate and heart rate. Technology Platform Pulsed radar as its sensor technology. Pulsed radar as its sensor technology. Digital recorder connected to commercially available electrodes, cannulas, and thermistors. RR Measurement Range 7 - 38 breaths per minute Not available. Not available. Sampling rate of RR data 0.333 Hz Not available. Not available. Update/Transmission Rate 0.333 Hz Not available. No real-time data, offline analysis only.

Summary of Non-Clinical Testing The following tests were performed to demonstrate safety and effectiveness of The Circadia C100 System based on current industry standards:

● Cleaning: General cleaning procedure for monitor enclosure is recommended in the Instructions for Use.

● Biocompatibility: Not applicable as there is no direct/indirect patient contacting components.

● Software Verification: The software development and testing were executed with consideration to IEC 62304 Medical device software – Software life cycle processes.

● Electromagnetic Compatibility, Electrical Safety, Wireless Coexistence and Battery Safety: The subject device is tested in compliance with: o IEC 60601-1:2005, COR1:2006, COR2:2007, AMD1:2012 (or IEC 60601-1:2012 reprint) Medical electrical equipment, Part 1: General requirements for basic safety and essential performance o IEC 60601-1-2:2014, Medical Electrical Equipment - Part 1-2: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Compatibility - Requirements And Tests o IEEE C63.27-2017 - American National Standard for Evaluation of Wireless Coexistence

● Performance Testing - Bench: A number of bench testing were executed using internal test protocols to demonstrate The C100 Circadia System performance met acceptance: o Circadia Monitor Drop Test o Circadia Monitor Power Cord/Button Fatigue Test

Circadia believes that the aforementioned non-clinical testing demonstrate that the subject device is designed and manufactured in such a way that, when used under the conditions and for the purposes intended, the safety and effectiveness, as well as the performance characteristic of the subject device is substantial equivalent to the predicate device.

Summary of Clinical Testing To evaluate the performance of the Circadia C100 System, the subject device was compared to gold standard manually scored end-tidal CO2 capnography data (device cleared in K040875 and K120888) in 12 patients. Performance of the subject device was also compared to a chest and abdomen worn band (device cleared in K122516) in 26 patients. The accuracy of Respiration rate was found to be +/- 2 breaths/min (accuracy rate 88.2%) and the 95% limits of agreements was -3.2 to +0.7 breaths/min. Thus the aforementioned clinical testing demonstrate that the overall performance of the subject device on a total of 38 subjects with a wide range of age, body- mass index, and gender, as well as various health conditions, subject postures, aspect angle, monitoring distance, presence of duvet, etc. to reflect intended user profile and conditions, for spot and continuous measurement, supports substantial equivalence to the predicate.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026